Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

Clinical trial NCT04425733 · WITHDRAWN

Trial details

NCT number: NCT04425733
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)Pneumonia Hypoxemia

Start date: 2020-07-07
Primary completion: 2020-11-10
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.